Relation of serum sialic acid to blood coagulation activity in type 2 diabetes

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 8, 2002, Pages 691-696

  Wakabayashi, Ichiro ^a   Masuda, H ^b  

^a YAMAGATA UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Diabetes mellitus; Fibrinogen; Platelet; Sialic acid; Thrombosis

Indexed keywords

ALPHA 2 ANTIPLASMIN; D DIMER; FIBRINOGEN; PLASMIN; SIALIC ACID; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CORRELATION COEFFICIENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; THROMBOSIS;

EID: 0036910961     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200212000-00004     Document Type: Article

References (30)

1. Lindberg G, Eklund GA, Gullberg B, Råstam L. Serum sialic acid concentration and cardiovascular mortality. BMJ 1991; 302: 143-146.
2. Lindberg G, Råstam L, Gullberg B, Eklund GA. Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: Multivariate analysis including 54,385 men and women during 20.5 years follow-up. Int J Epidemiol 1992; 21: 253-257.
3. Meade TW, North WRS, Chakrabarti R, Stirling Y, Haines AP, Thompson SG. Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1980; 1: 1050-1053.
4. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505.
5. Thomas DP, Roberts HR. Hypercoagulability in venous and arterial thrombosis. Ann Intern Med 1997; 126: 638-644.
6. Sueishi K, Ichikawa K, Kato K, Nakagawa K, Chen YX. Atherosclerosis: Coagulation and fibrinolysis. Semin Thromb Hemost 1998; 24: 255-260.
7. Sakamoto N, Hotta N, Toyota T, Ikeda Y, Matsuoka K, Kasuga M, Kikkawa R. The causes of death in Japanese diabetics based on survey results among 11648 diabetics during 1981-1990. Report of committee on cause of death in diabetes mellitus. J Jpn Diabetes Soc 1996; 39: 221-236
8. Ceriello A. Coagulation activation in diabetes mellitus: The role of hyperglycaemia and therapeutic prospects. Diabetologia 1993; 36: 1119-1125.
9. Carr ME. Diabetes mellitus: A hypercoagulable state. J Diabetes Complicat 2001; 15: 44-54.
10. Crook MA, Earle K, Morocutti A, Yip J, Viberti G, Pickup JC. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care 1994; 17: 305-310.
11. Tomino Y, Inoue W, Yagame M, Nomoto Y, Sakai H, Ito K, et al. Measurement of sialic acid and acute phase reactant proteins in sera of patients with diabetic nephropathy. J Diabetic Complicat 1988; 2: 175-178.
12. Yokoyama H, Jensen JS, Jensen T, Deckert T. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy. J Int Med 1995; 237: 519-523.
13. Crook MA, Couchman S, Tutt P. Plasma fibrinogen and its relationship to plasma sialic acid in non-insulin-dependent diabetes mellitus. Blood Coagul Fibrinolysis 1996; 7: 586-589.
14. Kario K, Matsuo T. Relation between sialic acid concentrations and the haemostatic system in the elderly. BMJ 1993; 306:1650-1651.
15. Ernst E. Koenig W. Fibrinogen and cardiovascular risk. Vasc Med 1997; 2: 115-125.
16. Crook MA, Tutt P, Simpson H, Pickup JC. Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus. Clin Chim Acta 1993; 219: 131-138.
17. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41: 1241-1248.
18. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334.
19. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
20. Friedewald WJ, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 459-502.
21. Young DS. Implementation of SI units for clinical laboratory data. Style specifications and conversion tables. Ann Intern Med 1987; 106: 114-129.
22. Lindberg G, Råstam L, Gullberg B, Eklund GA, Tornberg S. Serum sialic acid concentration and smoking: A population based study. BMJ 1991; 303: 1306-1307.
23. Crook M, Tutt P. Serum sialic acid concentration in patients with hypertriglyceridaemia showing the Frederickson's IIB phenotype. Clin Sci 1992; 83: 593-595.
24. Wakabayashi I, Sakamoto K, Yoshimoto S, Masui H. Relation of serum sialic acid to lipid concentrations. BMJ 1992; 305: 562-563.
25. Wakabayashi I, Sakamoto K, Yoshimoto S, Kakishita E. Serum sialic acid concentration and atherosclerotic risk factors. J Atheroscler Thromb 1994; 1: 113-117.
26. Lindberg G, Iso H, Råstam L, Lundblad A, Folsom AR. Serum sialic acid and its correlates in community samples from Akita, Japan and Minneapolis, USA. Int J Epidemiol 1997; 26: 58-63.
27. Pisa Z, Uemura K. Trends of mortality from ischaemic heart disease and other cardiovascular diseases in 27 countries, 1968-1977. World Health Stat Q 1982; 35: 11-47.
28. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham Study. Am Heart J 1987; 113: 1006-1010.
29. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991; 84: 613-617.
30. Bithell TC. Thrombocytosis. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (editors): Wintrobe's Clinical Hematology. Philadelphia, PA: Lea & Febiger; 1993. vol. 2. pp. 1390-1396.